Clinical trial

Effects of Repeated Psilocybin Dosing in OCD

Yale UniversityActive, not recruitingPhase 1Started Jul 20, 202328 enrolledUnited StatesNCT05370911

Abstract

This study aims to investigate the effects of repeated dosing of oral psilocybin on obsessive-compulsive disorder (OCD) symptomatology in a randomized, waitlist-controlled design with blinded independent ratings, and assess psychological mechanisms that may mediate psilocybin's therapeutic effects on OCD.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinOCD

Keywords

Obsessive-Compulsive Disorder

View on registry

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

This study's objects

Directly linked records, matched by DOI, trial reference, or registry, not just topic.

Publications from this trial

ArticlePsilocybin

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.

Davis AK, Barrett FS, May DG +5

ArticlePsilocybin

Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.

Ching THW, Amoroso L, Bohner C +15

Related research

TrialPsilocybin

Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.

ClinicalTrials.gov2026

TrialPsilocybin

Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.

ClinicalTrials.gov2018

TrialPsilocybin

Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics

ClinicalTrials.gov2024